Antiarrhythmic effects of baroreceptor activation therapy in chronic heart failure: a case report.
Dong WangChristian VeltmannJohann BauersachsDavid DunckerPublished in: European heart journal. Case reports (2023)
We present a patient with an extensive cardiovascular history and fully exploited pharmacologic and device-related therapy, who showed improvement in New York Heart Association (NYHA) functional classification, left ventricular systolic function, and reduction of arrhythmic events following implantation of the BAT device. This case presents an additional positive potential of BAT for HF patients in terms of reduction of arrhythmia burden. These results should be confirmed by further clinical trials.
Keyphrases
- left ventricular
- ejection fraction
- heart failure
- clinical trial
- end stage renal disease
- newly diagnosed
- aortic stenosis
- chronic kidney disease
- machine learning
- blood pressure
- deep learning
- case report
- acute myocardial infarction
- stem cells
- risk factors
- randomized controlled trial
- atrial fibrillation
- risk assessment
- left atrial
- hypertrophic cardiomyopathy
- catheter ablation
- mitral valve
- cardiac resynchronization therapy
- open label
- aortic valve